The Director of Drugs and Herbal Medicine Registration at the Food and Drugs Authority (FDA), Samuel Asante Boateng, has called on health sector stakeholders to prioritise product safety and align with international standards.
Speaking at a stakeholder dialogue organised by the Health CEOs and Scientists Network in Accra on May 22, 2025, Boateng emphasised FDA's uncompromising stance on safety, particularly in the herbal and traditional medicine space. "We have to make sure that the safety of products is ensured before we register, otherwise the FDA will be blamed. "We at the FDA have raised our standards, so we also call on the stakeholders to meet such standards, which align with the international ones," he stated.
The event, themed "Raising Standards in Meeting Global Demands," brought together major regulatory agencies including the Health Facilities Regulatory Agency (HEFRA) and the Traditional Medicine Practice Council (TMPC) to engage practitioners and stakeholders on regulation, safety, and innovation.
Kwame Dzikunu, President of the Health CEOs and Scientists Network, said the event was organised to bridge the communication gap between regulators and practitioners. "We want to understand their activities and also share the challenges we face in enhancing outstanding health practices in the country," he said.
